Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system.

about

Non-invasive inhaled nitric oxide in the treatment of hypoxemic respiratory failure in term and preterm infants.

P2860

Q39316619-B64E79C8-3498-4019-BF4D-C31C2C2ED84C

P2860

Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system.

Item

http://www.wikidata.org/entity/Q49076956

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Delivery characteristics of a ...... sitive airway pressure system.

@en

Delivery characteristics of a ...... sitive airway pressure system.

@nl

type

Item

label

Delivery characteristics of a ...... sitive airway pressure system.

@en

Delivery characteristics of a ...... sitive airway pressure system.

@nl

prefLabel

Delivery characteristics of a ...... sitive airway pressure system.

@en

Delivery characteristics of a ...... sitive airway pressure system.

@nl

P1476

Delivery characteristics of a ...... sitive airway pressure system.

@en

P2093

Frostell CG

http://www.w3.org/2001/XMLSchema#string

Lindwall R

http://www.w3.org/2001/XMLSchema#string

Lönnqvist PA

http://www.w3.org/2001/XMLSchema#string

P2860

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.

Nitric oxide administration using constant-flow ventilation.

A differential paramagnetic sensor for breath-by-breath oximetry.

Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal.

Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis.

Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances.

Inhaled nitric oxide in newborn and paediatric patients with pulmonary hypertension and moderate to severe impaired oxygenation: effects of doses of 3-100 parts per million.

Repair of ventricular septal defect in a child with severe pulmonary hypertension-response to inhaled nitric oxide.

Endogenous nitric oxide in the upper airways of healthy newborn infants.

Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study.

P304

530-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1460-9592.2002.00898.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12139595

http://www.w3.org/2001/XMLSchema#string

Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system.

about

P2860

P2860

Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698